Our latest news, insights & events
California is poised to lead the nation in regulating artificial intelligence with several major bills awaiting the Governor’s signature. The
AI Governance in California: Pioneering New Safety Standards
“[B]ut given the nature of the firm, there are a lot of native English-speakers (including other Australians), which makes it
Australian Jewish News – Ben Pask
Congratulations to our clients Payoneer on finalizing a lease agreement to move their Israel office to the 44-story Allied-BIG Tower
Payoneer will be moving to its new offices in Glilot
Dear Friends, Clients and Colleagues, We wanted to bring to your attention two important matters that were discussed by the
Key Updates from the Israel Tax Authority: No Estate Tax Legislation Planned and New Voluntary Disclosure Procedure Imminent
Following the success of our last “Law of the Draw” event, we’re thrilled to announce our upcoming follow-up event together
Law of the draw: next level
Dear Clients, Colleagues, and Friends, We usually use these updates to keep you notified of regulatory and legal developments, but
Herzog wins the most Tier-1 rankings in ITR World Tax 2025: Israel
Herzog Partner Liran Barak, head of our Gaming Regulation practice, recently published an overview of Israel’s gaming and gambling regime in
Israel’s Conservative Stance on Gambling: Legal Framework, Exceptions, and Emerging Trends
Founders’ Equity: Key Considerations for Israeli-Related Tech Startups In the dynamic ecosystem of Israeli tech startups, equity arrangements for founders
Founders’ Equity: Key Considerations for Israeli-Related Tech Startups
Dear Clients, Colleagues, and Friends, New Court Decision Addresses Certain Tax Aspects Related to the Valuation of IP
Israeli Court Ruling Offers Insights on IP Valuation Principles for Tax Purposes
We previously reported on a growing litigation trend in the United States, as social gaming casinos and sweepstakes operators have
Breaking Down the Latest Sweepstake and Social Casino Lawsuits and Enforcement in the United States and Australia
Congratulations to our client, Silexion Therapeutics Ltd., a clinical-stage, oncology-focused biotechnology company, for closing a business combination with Moringa Acquisition
